| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
355,150,000 |
| Market
Cap: |
2.24(B) |
| Last
Volume: |
17,273,575 |
Avg
Vol: |
17,226,848 |
| 52
Week Range: |
$6.1 - $10.61 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Bausch Health Companies develops, manufactures and markets, primarily in the therapeutic areas of eye-health, gastroenterology and dermatology, a range of: pharmaceuticals, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices). Co.'s portfolio of products falls into four operating and reportable segments: Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
6,313 |
13,261 |
14,828 |
| Total Sell Value |
$0 |
$61,867 |
$119,170 |
$133,715 |
| Total People Sold |
0 |
1 |
1 |
1 |
| Total Sell Transactions |
0 |
1 |
4 |
7 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Valueact Holdings Gp, Llc |
See Remarks |
– • – |
2017-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
25,406 |
38,209 |
|
- |
|
| Kavanagh Sarah B |
Director |
– • – |
2017-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
25,406 |
39,864 |
|
- |
|
| Robertson Russel C |
Director |
– • – |
2017-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
25,406 |
49,271 |
|
- |
|
| Karabelas Argeris N |
Director |
– • – |
2017-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
25,406 |
46,132 |
|
- |
|
| Eshelman Fredric N |
Director |
– • – |
2017-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
25,406 |
38,298 |
|
- |
|
| Valueact Holdings Gp, Llc |
See Remarks |
– • – |
2017-05-03 |
4 |
D |
$9.66 |
$37,896 |
D/D |
(3,923) |
12,803 |
|
- |
|
| Eshelman Fredric N |
Director |
– • – |
2017-05-03 |
4 |
D |
$9.66 |
$47,373 |
D/D |
(4,904) |
12,892 |
|
- |
|
| Wechsler Amy B |
Director |
– • – |
2017-03-31 |
4 |
A |
$11.03 |
$27,134 |
D/D |
2,460 |
22,150 |
|
- |
|
| Robertson Russel C |
Director |
– • – |
2017-03-31 |
4 |
A |
$11.03 |
$34,491 |
D/D |
3,127 |
23,865 |
|
- |
|
| Ingram Robert Alexander |
Director |
– • – |
2017-03-31 |
4 |
A |
$11.03 |
$23,384 |
D/D |
2,120 |
92,046 |
|
- |
|
| De Schutter Richard U |
Director |
– • – |
2017-03-31 |
4 |
A |
$11.03 |
$23,428 |
D/D |
2,124 |
27,314 |
|
- |
|
| Appio Thomas |
EVP, COMPANY GROUP CHAIRMAN |
• – – |
2017-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
63,742 |
98,149 |
|
- |
|
| De Schutter Richard U |
Director |
– • – |
2017-03-15 |
4 |
B |
$10.80 |
$108,000 |
D/D |
10,000 |
25,190 |
2.39 |
- |
|
| Herendeen Paul |
EVP and CFO |
• – – |
2017-03-14 |
4 |
B |
$10.72 |
$257,280 |
D/D |
24,000 |
174,000 |
2.74 |
- |
|
| Valueact Holdings Gp, Llc |
See Remarks |
– • – |
2017-03-14 |
4 |
B |
$10.81 |
$32,465,000 |
I/I |
3,000,000 |
16,937,431 |
2.1 |
- |
|
| Appio Thomas |
EVP, Company Groupo Chairman |
• – – |
2017-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
12,287 |
34,407 |
|
- |
|
| Ackermann Christina |
EVP and General Counsel |
• – – |
2017-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
24,575 |
68,419 |
|
- |
|
| De Schutter Richard U |
Director |
– • – |
2017-01-03 |
4 |
A |
$15.24 |
$170,536 |
D/D |
11,190 |
15,190 |
|
- |
|
| De Schutter Richard U |
Director |
– • – |
2017-01-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,000 |
|
- |
|
| Humphries William D. |
EVP, Company Group Chairman |
• – – |
2017-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
129,838 |
129,838 |
|
- |
|
| Wechsler Amy B |
Director |
– • – |
2016-12-30 |
4 |
A |
$14.52 |
$24,989 |
D/D |
1,721 |
19,690 |
|
- |
|
| Robertson Russel C |
Director |
– • – |
2016-12-30 |
4 |
A |
$14.52 |
$33,744 |
D/D |
2,324 |
20,738 |
|
- |
|
| Ingram Robert Alexander |
Director |
– • – |
2016-12-30 |
4 |
A |
$14.52 |
$21,243 |
D/D |
1,463 |
89,926 |
|
- |
|
| Ross Thomas W. Sr. |
Director |
– • – |
2016-12-14 |
4 |
B |
$14.73 |
$73,650 |
D/D |
5,000 |
26,822 |
2.39 |
- |
|
| Ackman William A |
Director |
– • – |
2016-12-12 |
4 |
S |
$14.85 |
$51,628,847 |
I/I |
(3,476,690) |
18,114,432 |
|
- |
|
705 Records found
|
|
Page 21 of 29 |
|
|
0.15 (2.43%) 
